GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Retained Earnings

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Retained Earnings : ¥10,087 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. China Resources Double-Crane Pharmaceutical Co's retained earnings for the quarter that ended in Mar. 2024 was ¥10,087 Mil.

China Resources Double-Crane Pharmaceutical Co's quarterly retained earnings increased from Sep. 2023 (¥9,338 Mil) to Dec. 2023 (¥9,671 Mil) and increased from Dec. 2023 (¥9,671 Mil) to Mar. 2024 (¥10,087 Mil).

China Resources Double-Crane Pharmaceutical Co's annual retained earnings increased from Dec. 2021 (¥8,196 Mil) to Dec. 2022 (¥8,934 Mil) and increased from Dec. 2022 (¥8,934 Mil) to Dec. 2023 (¥9,671 Mil).


China Resources Double-Crane Pharmaceutical Co Retained Earnings Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Retained Earnings Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,892.12 7,563.27 8,196.42 8,934.03 9,670.63

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,933.32 9,037.19 9,338.16 9,670.63 10,086.73

China Resources Double-Crane Pharmaceutical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
Executives
Yu Shun Ting Director
Han Shuo senior management
Liu Zi Qin senior management
Fan Yan Xi senior management
Lu Wen Chao Directors, senior managers
Man Chao senior management
Ni Jun senior management
Feng Yi Director
Zheng Ze Ping Supervisors
Li Ying senior management

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines